Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

Real-time PCR in Molecular Diagnostics

24 Oct 2012 - 26 Oct 2012 - Breda, The Netherlands

Bookmark and Share

Aim of the course:
Real time Polymerase Chain Reaction is becoming more and more important in almost all laboratories. Especially in diagnostic laboratories real time PCR is a new, and promising, technique to identify bacteria, viruses and genetic alterations in human cells. The aim of this international short-course is to give the participants an in-depth view in the theoretical and practical knowledge of real time PCR techniques in molecular diagnostics. State-of-the-art experts in the field of real time PCR techniques from several diagnostic laboratories will provide theoretical and practical expertise.

This course is developed for experienced laboratory technicians involved in the life sciences laboratories, incl. medical diagnostics, microbiology, genetics, pathology, immunology, etc.
Basic knowledge of molecular biology in general and PCR is a prerequisite. If you feel you lack the basic knowledge in PCR or the basic principles of real-time PCR, but you would like to participate in this quantitative PCR course, please note that the Avans Hogeschool also offers an international introductory short course: Principles, parameters, and applications of PCR (code 2545), which is especially suitable as a basic introduction to this course.

Course structure:
The course consists of a series of practical sessions interspersed with lectures and tutorials. 50% of the time is devoted to lectures and 50% is spent on "hands-on" experiments, covering techniques that may be directly applied in diagnostic laboratories. All participants will receive a practical manual containing all used protocols.

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos